If so, you may want to explore BPC-157 peptide therapy, which has demonstrated encouraging outcomes in treating various conditions
Tirzepatide, sold as Mounjaro and Zepbound, was not separately classified in the 2022 data and was not yet approved for weight management at that time, meaning it is not reflected in these figures
However, it doesn't address the underlying immune dysregulation
Athlete backed formulation
But if the probiotic needs to be taken indefinitely (as is the case with most probiotics that do not achieve permanent colonization), the lifetime cost adds up
Take a 30,000ft view, and you will see a classic case of what's known in the trade as drug repurposing